The Institutional Biosafety
Committee (IBC) insures that research involving
recombinant DNA and Biological Materials follow designated guidelines.
The IBC
follows the guidelines established by the National Institutes
of Health (NIH) Office
of Biotechnology Activities and the Center for Disease Control
(CDC).
Institutional
Biosafety Committee Meeting
August 17, 2009
October 19, 2009
December 14, 2009
January 25, 2010
March 15, 2010
May 17, 2010
Office of Research Compliance The University of North Carolina at Greensboro
2718 MHRA Bldg, 1111 Spring Garden Street
Greensboro, NC 27402-6170 VOICE 336.256.1482 FAX 336.256.1482